Article
An orally administered peptide hydrogel disentangles immune-microbiota crosstalk for long-term ulcerative colitis therapy
2026-08-24
Abstract excerpt
Ulcerative colitis (UC) is a global health challenge driven by immune dysregulation and gut microbiota imbalance.1 Current treatments, limited by insufficient efficacy and systemic toxicity during prolonged use, fail to resolve the intertwined immune-microbial pathology.2 Here, we report an orally administered self-assembled hydrogel C₁₂-(IIRR)₂I-NH₂ (CIR), engineered from host defense peptides, which disrupts the...
Topics
Open a Topic to create a Post that cites this publication.
- Bacteriophages and microbial interactions
- Clostridium difficile and Clostridium perfringens research
- Escherichia coli research studies
- Gut microbiota and health
- Probiotics and Fermented Foods
- RNA Interference and Gene Delivery
- SARS-CoV-2 and COVID-19 Research
- Viral gastroenteritis research and epidemiology
Identifiers and source
- Literature Corpus work
- d92ed4ff-1b8f-5759-98c2-ee2c49240fa5
- DOI
- 10.64898/2026.08.22.746417
